原发性醛固酮增多症中用于侧化判定及合并皮质醇过多的无创血清类固醇特征
本研究纳入2018至2022年间接受肾上腺静脉采血(AVS)的216例原发性醛固酮增多症(PA)患者,用液相色谱-质谱法检测19种类固醇及17项代谢比值。基于18-羟基皮质醇、醛固酮、11-羟基雄烯二酮的三类固醇模型判别侧化PA的AUC为0.821,与临床模型0.790相当(P=0.351);联合模型AUC达0.852,优于临床模型(P=0.002)。基线类固醇指标与术后生化成功无显著关联(P>0.05)。
要点
- 侧化PA的醛固酮与18-羟基皮质醇显著升高(P<0.001),11-羟基雄烯二酮降低(P=0.001)。
- 三类固醇模型AUC 0.821与临床模型0.790相当(P=0.351),联合模型AUC 0.852更优(P=0.002)。
- 侧化PA合并MACS者18-羟基皮质醇更高(年龄/性别校正P=0.038)。
核心结论
- 血清类固醇谱可能有助于在临床参数之外无创识别侧化型原发性醛固酮增多症。
- 合并轻度自主皮质醇分泌与雄激素抑制及类固醇模式改变相关,类固醇谱对治疗结局的预后作用需进一步研究。
研究设计与样本
- 研究纳入2018至2022年间接受肾上腺静脉采血的216例原发性醛固酮增多症患者。
- 采用液相色谱-质谱法检测19种肾上腺类固醇及17项代谢比值,并用随机森林递归特征消除进行特征筛选。
- 建立逻辑回归模型预测侧化型原发性醛固酮增多症及术后生化结局,以受试者工作特征分析评价模型性能。
主要发现
- 侧化型PA的醛固酮和18-羟基皮质醇显著高于双侧型PA(P<0.001),11-羟基雄烯二酮显著低于双侧型PA(P=0.001)。
- 含18-羟基皮质醇、醛固酮、11-羟基雄烯二酮的三类固醇模型AUC 0.821,与基于血钾、血浆醛固酮浓度、血浆肾素活性的临床模型AUC 0.790相比,差异无统计学意义(P=0.351)。
- 联合临床参数与18-羟基皮质醇、11-羟基雄烯二酮的模型AUC最高,为0.852,显著优于临床模型(P=0.002)。
- 侧化型PA合并轻度自主皮质醇分泌者的18-羟基皮质醇水平更高(年龄/性别校正P=0.038)。
- 基线类固醇标志物与术后生化成功无显著关联(P>0.05)。
关键数值与推荐
- 三类固醇模型(18-羟基皮质醇、醛固酮、11-羟基雄烯二酮)AUC 0.821 vs 临床模型AUC 0.790(P=0.351)。
- 联合模型(临床参数+18-羟基皮质醇+11-羟基雄烯二酮)AUC 0.852,显著优于临床模型(P=0.002)。
- 侧化型PA与双侧型PA比较:醛固酮与18-羟基皮质醇升高(P<0.001),11-羟基雄烯二酮降低(P=0.001)。
- 侧化型PA合并MACS者18-羟基皮质醇更高(年龄/性别校正P=0.038)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出类固醇谱对治疗结局的预后作用需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Adrenal venous sampling (AVS) remains the gold standard for primary aldosteronism (PA) subtyping but is invasive and technically demanding. We investigated whether peripheral steroid profiles could serve as a noninvasive tool for PA subtyping, characterizing the presence of coexisting mild autonomous cortisol secretion (MACS), and predicting biochemical outcomes after adrenalectomy. METHODS: In total, 216 patients with PA who underwent AVS between 2018 and 2022 were enrolled. Serum steroid profiling quantified 19 adrenal steroids and 17 metabolic ratios using liquid chromatography-mass spectrometry. Feature selection was performed using random forest-based recursive feature elimination. Logistic regression models were developed to predict lateralized PA and postoperative biochemical outcomes. Model performance was evaluated using receiver operating characteristic analysis. RESULTS: Lateralized PA showed significantly higher aldosterone and 18-hydroxycortisol (18-OHF) (P<0.001) but lower 11-hydroxyandrostenedione (11-OHA4) (P=0.001) than bilateral PA. A three-steroid model (18-OHF, aldosterone, 11-OHA4) showed discrimination comparable to a clinical model based on serum potassium, plasma aldosterone concentration, and plasma renin activity (AUC 0.821 vs. 0.790; P=0.351). A combined model integrating the clinical parameters with 18-OHF and 11-OHA4 achieved the highest performance (AUC 0.852), significantly outperforming the clinical model (P=0.002). Patients with lateralized PA and MACS had higher 18-OHF levels (age/sex-adjusted P=0.038). Baseline steroid markers were not significantly associated with post-surgical biochemical success (P>0.05). CONCLUSION: Serum steroid profiling may facilitate the noninvasive identification of lateralized PA beyond clinical parameters alone. Coexisting MACS was associated with androgen suppression and altered steroid patterns, while the prognostic role of steroid profiles for treatment outcomes requires further investigation.
引用
- Park SS, Noh J, Jung S, et al. Noninvasive serum steroid signatures of lateralization and coexisting cortisol excess in primary aldosteronism. J Clin Endocrinol Metab. 2026. PMID: 43004931. doi:10.1210/clinem/dgag454
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。